Admin, Author at Channelchek

Research – Coeur Mining (CDE) – Review of first quarter 2019

Posted on May 3, 2019May 4, 2022 by Admin

Friday, May 3, 2019

Coeur Mining (CDE)

Should Investors Count On A Better Second Half?

Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. The company is involved on the discovery and mining of gold and silver, and generates the vast majority of revenue from the sale of these precious metals. The operating mines of company are palmarejo, rochester, wharf, and kensington.

Mark Reichman, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to full report for price target, fundamental analysis and rating.

EBITDA in line with our estimate. Coeur Mining reported adjusted EBITDA of $26.1 million versus $49.2 million during the first quarter of 2018 and our estimate of $26.0 million. The company reported a first quarter adjusted loss of ($0.11) per share, compared to $0.00 during the prior year period and our estimate of ($0.07).
Updating estimates. We now forecast a 2019 loss of ($0.35) per share and EBITDA of $146.8 million versus our previous estimates of ($0.22) and $156.0 million. In 2020, we project a loss of ($0.05) per share and EBITDA of $205.1 mill…

Get full report on Channelchek desktop.

*Analyst
certification and important disclosures included in full report.
NOTE: investment decisions should not be based upon the content of
this research summary. Proper due diligence is required before
making any investment decision.

Research – ACCO Brands (ACCO) – Raising price target

Posted on May 3, 2019May 4, 2022 by Admin

Friday, May 3, 2019

ACCO Brands Corporation (ACCO)

Can ACCO Brands Maintain the Momentum?

ACCO Brands Corporation designs, manufactures, sources, markets, and sells office products, academic supplies, and calendar products primarily in the United States, Canada, Northern Europe, Brazil, Australia, and Mexico. It operates through three segments: ACCO Brands North America, ACCO Brands EMEA, and ACCO Brands International.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to full report for price target, fundamental analysis and rating.

Solid 1Q19 Results. ACCO brands reported solid 1Q19 results, exceeding our estimates. Revenue came in at $393.9 million and adjusted EPS at $0.08. We were projecting $381.5 million and $0.06, respectively.
EMEA and North America Drove
Results. EMEA posted a 3.5% comp sales increase and slightly higher operating income, excluding adverse foreign currency. Although North American comp sales fell 2.5%, the decline was significantly less than the sec…

Get full report on Channelchek desktop.

News – Game of Thrones: Energy Battles

Posted on May 3, 2019May 4, 2022 by Admin

Who will sit on the oil throne?

(Note: companies that could be impacted by the content of this article are listed at the base of the story (desktop version). This article uses third-party references to provide a bullish, bearish and balanced point of view; sources listed in the “Balanced” section)

On
April 12^th, Chevron Corp agreed to buy Anadarko Petroleum Corp for
$50 billion including debt. The
acquisition would make Chevron as big as Exxon and Shell and double down its
position in the Permian Oil Basin, a region between western Texas and
southeastern New Mexico. Not to be
outdone, Occidental Petroleum offered Anadarko a $57 billion takeout bid
starting the first takeover battle for a major oil company in years. As expected, energy stocks have been strong
in reaction to the news. Whether or not
the acquisition is the first in a wave of consolidation remains to be
seen. Below, we discuss several
arguments for and against further industry consolidation.

Research – Aurania Resources (ARU.V) – Drilling results analysis

Posted on May 3, 2019May 4, 2022 by Admin

Friday, May 3, 2019

Aurania Resources Ltd. (ARU:CA)

Putting Crunchy Hill Results In Perspective.

Aurania Resources Ltd. is a Canada-based junior mining exploration company engaged in the identification, evaluation, acquisition, and exploration of mineral property interests, with a focus on precious metals and copper. Its flagship asset, The Lost Cities-Cutucu Project, is in southeastern Ecuador in the Province of Morona-Santiago. The company also has several minor projects in Switzerland.

Mark Reichman, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to full report for price target, fundamental analysis and rating.

Scout drilling at Crunchy Hill
nearing completion. Seven bore holes have been completed for a total of 2,600 meters. While minerals collected from the initial drilling confirmed indications of an epithermal gold-silver system, no significant vein systems have been intersected to date. An eighth hole is being drilled with a ninth being considered before moving on to the next target. Therefore, it may be premature to render a final verdict on Crunchy Hill’s potential.
Assay results. Assay results have been received for the first hole, in which 8 meters returned 1.1 grams per tonne of silver and 13.2 meters returned 1.8 grams per tonne of silver but neither returned much in the way of gold. Core sampling has been completed up to and including the si…

Get full report on Channelchek desktop.

Research – Albany International (AIN) – First quarter 2019 review

Posted on May 2, 2019May 4, 2022 by Admin

Thursday, May 2, 2019

Albany International (AIN)

What’s in management’s secret recipe for margin enhancement?

Albany International Corp. is a textiles and materials processing company. The Company operates through two segments: Machine Clothing (MC) and Albany Engineered Composites (AEC). Its MC segment supplies permeable and impermeable belts used in the manufacture of paper, paperboard, nonwovens, fiber cement and various other industrial applications.

Christian Herbosa, Research Analyst, Noble Capital Markets, Inc.

Refer to full report for price target, fundamental analysis and rating.

Profitability Boost. In Q1, AIN saw meaningful improvements in profitability, increasing gross profit, operating profit, and adjusted EBITDA over Q1 last year by 18%, 135%, and 22.3% respectively. These improvements were largely driven higher net sales, as well as, labor productivity gains and overall equipment effectiveness improvements.
Additional Guidance Provided. Management updated the previously provided 2019 guidance with enhanced details. Notably, managem…

Get full report on Channelchek desktop.

*Analyst
certification and important disclosures included in full report.
NOTE: investment decisions should not be based upon the content of
this research summary. Proper due diligence is required before
making any investment decision.

Research – Great Lakes Dredge & Dock (GLDD) – Strong third quarter

Posted on May 1, 2019May 4, 2022 by Admin

Wednesday, May 1, 2019

Great Lakes Dredge & Dock (GLDD)

Third Strong Quarter in a Row – 2019 Off to a Great Start.

Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The Company operates in two operating segments namely Dredging and Environmental, and Infrastructure.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to full report for price target, fundamental analysis and rating.

Staying on track with another
quarter of strong execution. For the third quarter in a row, dredging operating results
were strong. Adjusted dredging EBITDA of $43.8 million soundly beat our
$26.4 million estimate and was well above 1Q2018 adjusted EBITDA of $16.6
million. Continued solid project execution and two unexpected events (~$15
million) had a positive impact.
Increasing 2019 EBITDA estimate.
Improved execution and dredging market strength reinforces positive outlook. Our 2019 EBITDA estimate moves to $126.1 million from
$120.1 million to reflect the st…

Get full report on Channelchek desktop.

Research – 1-800-Flowers.com (FLWS) – Fiscal 3Q19 Update

Posted on May 1, 2019May 4, 2022 by Admin

Wednesday, May 1, 2019

1-800-Flowers.com, Inc (FLWS)

Winning Doesn’t Get Boring.

1-800 Flowers.com Inc is a United-States-based provider of gourmet food & gift baskets, consumer floral, and BloomNet wire service. Gourmet food & gift baskets and consumer floral jointly account for the majority of the company’s total revenue. The company provides a broad range of merchandise, including fresh flowers, premium, fruits, popcorn, specialty treats, cookies and baked gifts, premium chocolates, confectionery, gift baskets, premium English muffins, steaks and chops, and others.

Michael Kupinski, DOR, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to full report for price target, fundamental analysis and rating.

Solid quarter. The fiscal third quarter revenues of $248.4 million
beat our $242.0 million estimate, while adjusted EBITDA loss of $4.4 million
came in lower than our loss estimate of a $5.8 million loss. For a third
straight quarter, BloomNet was strong with 15.1% revenue growth and an
impressive 12.3% increase in adjusted EBITDA.
Raised guidance. Full fiscal year 2019 revenues and adjusted EBITDA were
guided at the high end of the previously guidance range from $1232.6 million to
$1244.1 million and $80.0 million to $82.0 million, respec…

Get full report on Channelchek desktop.

FEATURE: Research Initiation | Tax Cuts | Blockchain | Podcast

Posted on May 1, 2019 by Admin

1-800-Flowers.com, Inc
(FLWS) Winning Doesn’t Get Boring. More

Great Lakes Dredge & Dock (GLDD) Third Strong Quarter in
a Row – 2019 Off to a Great Start. More

INITIATION – Genprex Inc (GNPX) Poised to Emerge as a Leader in Cancer
Gene Therapy. More

Did the Tax Cuts and Jobs Act Reduce People’s Federal Taxes? Was
your tax refund what you hoped it would be? The stories are commonplace in the
news and on social media: the taxpayer who either received less of a refund in
2019 compared to what they received in 2018 or, even worse, went from receiving
a refund in 2018 to having to write a check for taxes owed in 2019. More

What’s the deal with enterprise blockchain? How are
businesses using blockchain? Businesses are finding that blockchain, the
technology behind Bitcoin and other cryptocurrencies, has far wider and more
useful applications than creating speculative digital currency markets. More

IPO Podcast Episode 2: Drug Disruption. Brant Pinvidic (host of the iTunes top-trending Hollywood podcast “Why I’m Not…”) probes into the positive aspects of being “disruptive” in healthcare. Changing what is viewed as the norm – disrupting the status quo -can result in very positive change… Like Uber and Airbnb. Here Brant looks for disruption in healthcare; ways to reduce the costs associated with prescription drugs. He interviews the CEO of Dyadic International who believes his company has the answer. You be the judge. More

Sierra Metals Reports Q1-2019 Financial Results at Its
Sociedad Minera Corona Subsidiary in Peru. More

Research – Comtech (CMTL) – Analysis of new contract and acquisition

Posted on April 30, 2019May 4, 2022 by Admin

Tuesday, April 30, 2019

Comtech Telecommunications (CMTL)

What Will the New Contract and Acquisition Mean?

Comtech Telecommunications Corp. engages in the design, development, production, and marketing of products, systems, and services for advanced communications solutions in the United States and internationally. It operates in three segments: Telecommunications Transmission, Mobile Data Communications, and RF Microwave Amplifiers.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to full report for price target, fundamental analysis and rating.

Awarded New Contract. Comtech
announced yesterday that it has been awarded a five-year contract valued in
excess of $100 million to develop, implement, and operate a Next-Generation 911
emergency communications system for a Northeastern state. We believe the state
to be Massachusetts where General Dynamics had a major contract.
Acquires NG-911 Business. In
conjunction with the award, Comtech also announced the acquisition of the state
and local government NG-911 business from General Dynamics. Coming on the heels
of the Solacom acqui…

Get full report on Channelchek desktop.

Research – Scorpio Bulkers (SALT) – First Quarter 2019 Review

Posted on April 30, 2019May 4, 2022 by Admin

Tuesday, April 30, 2019

Scorpio Bulkers Inc. (SALT)

Recovery Under Way – Worst Might Be Passing.

Scorpio Bulkers Inc is a shipping company based in Monaco. It owns and operates a fleet of modern mid to large-size dry bulk carriers which provide marine transportation for major bulks, which include iron ore, coal and grain and minor bulks which include bauxite, fertilizers and steel products internationally.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to full report for price target, fundamental analysis and rating.

1Q2019 Results
slightly ahead of recent revisions. Adjusted EBITDA of $17.3 million was in line with our
estimate of $16.0 million mainly due to higher shipping days, which drove a
$1.9 million revenue variance and more than offset higher opex (-$0.5 million)
and cash G&A expenses (-$0.1 million). Please note that 1Q2019 EBITDA
excludes a non-cash gain of $15.3 million on the Scorpio Tankers (STNG)
investment.
Adjusting estimates to reflect 1Q2019 results, 2Q2019 contract cover, financing activity, timing of scrubber installations and recent dry bulk market weakness.
Our 2019 EBITDA estimate is $89.8 million (from $86.3
million) on TCE rates of $10,819/da…

Get full report on Channelchek desktop.

Research – Dyadic (DYAI) – Expanding partnership portfolio

Posted on April 30, 2019May 4, 2022 by Admin

Tuesday, April 30, 2019

Dyadic International (DYAI)

Sub-Licensing Agreement Providing Optionality for C1 Technology.

Dyadic International Inc. is a biotechnology company developing a proprietary C1 expression platform to express and manufacture biologic products. The C1 technology is part of a fungi expression system, which utilizes inexpensive substrates yielding a high level of production. Dyadic is currently improving and optimizing the production of biological products in a C1 expression system.

Ahu Demir, Ph.D., Biotechnology Research Analyst, Noble Capital Markets, Inc.

Refer to full report for price target, fundamental analysis and rating.

Announces significant licensing agreement. Australian based drug development and contract
manufacturing firm, Luina Bio, announced plans to utilize Dyadic’s C1 gene
expression technology platform for the development and commercialization of
biological products to prevent and treat animal diseases. This is the company’s
first sub-licensing agreement, which, we believe, validates the company’s
proprietary C1 technology.
Impressive list of partners. Luina Bio is the first licensing move for the company’s
technology and adds to a list of significant R&D partnerships with
pharmac…

Get full report on Channelchek desktop.

Research – TherapeuticsMD (TXMD) – Assumption of Coverage

Posted on April 29, 2019May 4, 2022 by Admin

Monday, April 29, 2019

TherapeuticsMD (TXMD)

Can the Early Commercial Success Eradicate the Stock Overhang?

TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products.

Ahu Demir, Ph.D., Biotechnology Research Analyst, Noble Capital Markets, Inc.

Refer to full report for price target, fundamental analysis and rating.

Assumption of Coverage with Outperform Rating and $13 Price
Target. We are assuming coverage of TherapeuticsMD with an Outperform rating and Price Target of $13, based on an NPV analysis of the
pipeline. Three product approvals were granted by the FDA in 2018 providing a
solid foundation for the company to become a significant player in the
women’s health space.
Strong Player in Women’s Health. Three product approvals granted in 2018 include; i) Imvexxy
for patients with vulvovaginal atrophy (VVA), ii) Bijuva (estradiol and
progesterone) to treat vasomot…

Get full report on Channelchek desktop.

Research – Genprex (GNPX) – Initiation of Coverage

Posted on April 26, 2019May 4, 2022 by Admin

Friday, April 26, 2019

Genprex (GNPX)

Poised to Emerge as a Leader in Cancer Gene Therapy.

Genprex Inc is a US-based clinical stage gene therapy company. It is engaged in developing a new approach to treating cancer, based upon its novel proprietary technology platform, including initial product candidate, Oncoprex immunogene therapy.

Cosme Ordoñez, M.D., Ph. D. , Life Sciences Analyst, Noble Capital Markets, Inc.

Refer to full report for price target, fundamental analysis and rating.

Coverage
Initiation. We are initiating coverage of Genprex, Inc. with an
Outperform Rating and a $5.00 target price.
Unique Gene
Therapy Technology. We believe that Genprex will emerge as a leader in the area
of gene therapy for the treatment of cancer. The Company is developing a unique
platform technology consisting on the use of lipid nano…

Get full report on Channelchek desktop.